Mar 30, 2017 11:03 am UTC| Business
Inivata and Gustave Roussy Publish Positive Results from Prospective Clinical Study in use of ctDNA Liquid Biopsy to Guide Cancer Treatment Publication in Annals of Oncology Shows Benefit of Osimertinib in...
Mar 30, 2017 11:03 am UTC| Business
Inivata and Gustave Roussy Publish Positive Results from Prospective Clinical Study in use of ctDNA Liquid Biopsy to Guide Cancer Treatment Publication in Annals of Oncology Shows Benefit of Osimertinib in...
Mar 30, 2017 11:03 am UTC| Business
Inivata and Gustave Roussy Publish Positive Results from Prospective Clinical Study in use of ctDNA Liquid Biopsy to Guide Cancer Treatment Publication in Annals of Oncology Shows Benefit of Osimertinib in...
Mar 30, 2017 11:02 am UTC| Business
SAN FRANCISCO, March 30, 2017 -- FibroGen, Inc. (NASDAQ:FGEN), a science-based biopharmaceutical company, today announced that clinical results from two Phase 2 studies in China of roxadustat for the treatment of anemia...
Mar 30, 2017 11:02 am UTC| Business
SAN FRANCISCO, March 30, 2017 -- FibroGen, Inc. (NASDAQ:FGEN), a science-based biopharmaceutical company, today announced that clinical results from two Phase 2 studies in China of roxadustat for the treatment of anemia...
Carbonite Announces Pricing of Private Offering of $125 Million of 2.50% Convertible Senior Notes
Mar 30, 2017 11:02 am UTC| Business
BOSTON, March 30, 2017 -- Carbonite, Inc. (NASDAQ:CARB) (“Carbonite” or the “Company”) announced today the pricing of its previously announced private offering of $125 million aggregate principal amount of 2.50%...
NeuroDerm Announces Fourth Quarter and Full Year 2016 Financial Results
Mar 30, 2017 11:02 am UTC| Business
Files Annual Report on Form 20-F Company to Host Conference Call and Webcast Today at 8:30 a.m. ET REHOVOT, Israel, March 30, 2017 -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company...
US–India Trade Talks Race Toward USD 500 Billion Goal